Home › Medullary Carcinoma › NCT04216732
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Aims 1 and 2: A diagnosis of MTC * Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment * Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team * Aim 3: A current registrant in the MTCR
About the study
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
What is being tested
- Blood Pressure Measurement (other)
- Questionnaire Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 2,030 · Started: Jan 10, 2020
Contact the study team
- Elizabeth G Grubbs · Phone: 713-792-6940
Official record on ClinicalTrials.gov — NCT04216732
Locations in the U.S.
| California | University of California San Francisco, San Francisco |
| Texas | M D Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.